Efficacy and safety of methotrexate versus placebo as add-on therapy to H1 antihistamines for patients with difficult-to-treat chronic spontaneous urticaria: A randomized, controlled trial - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement Access content directly
Journal Articles Journal of The American Academy of Dermatology Year : 2020

Efficacy and safety of methotrexate versus placebo as add-on therapy to H1 antihistamines for patients with difficult-to-treat chronic spontaneous urticaria: A randomized, controlled trial

Angele Soria
Fichier principal
Vignette du fichier
S0190962219324909.pdf (327.73 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-02623128 , version 1 (21-07-2022)

Licence

Attribution - NonCommercial - CC BY 4.0

Identifiers

Cite

Sophie Leducq, Mahtab Samimi, Claire Bernier, Angele Soria, Emmanuelle Amsler, et al.. Efficacy and safety of methotrexate versus placebo as add-on therapy to H1 antihistamines for patients with difficult-to-treat chronic spontaneous urticaria: A randomized, controlled trial. Journal of The American Academy of Dermatology, 2020, 82 (1), pp.240-243. ⟨10.1016/j.jaad.2019.07.097⟩. ⟨hal-02623128⟩
55 View
19 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More